This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAM 7.5 MG TAB is a generic product labeled by SpecGx LLC, priced at $0.2759 per EA under NDC 00406888401. Its NADAC has been published 370 times since Sep 4, 2019.
FDA first approved this application on Oct 7, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAM 7.5 MG TAB
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine SulfateStrength
1.875; 1.875; 1.875; 1.875 mg/1; mg/1; mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406888401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040440FDA Approved
10/7/2003
TE Code
AB
On Market Since
10/7/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has been published 370 times since Sep 4, 2019, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2759 per EA |
|---|---|
| All-time high | $0.8329 (Sep 16, 2020) |
| All-time low | $0.1857 (Nov 20, 2024) |
| 52-week high | $0.3070 |
| 52-week low | $0.2582 |
| Median price | $0.4223 |
| Average price | $0.4699 |
| Largest weekly change | +86.1% (Mar 17, 2021) |
| Weeks tracked | 370 |
| Tracking since | Sep 4, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 7.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 7.5 MG TAB, manufactured by SpecGx LLC, is $0.2759 per EA (NDC 00406888401), effective Sep 30, 2026.
How has the price of DEXTROAMP-AMPHETAM 7.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has declined 53.6%. It has been tracked across 370 weekly CMS publications since Sep 4, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 7.5 MG TAB?
Since Sep 4, 2019, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has ranged from a low of $0.1857 (Nov 20, 2024) to a high of $0.8329 (Sep 16, 2020), with a median of $0.4223 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 7.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAM 7.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAM 7.5 MG TAB?
DEXTROAMP-AMPHETAM 7.5 MG TAB (NDC 00406888401) is labeled by SpecGx LLC, and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAM 7.5 MG TAB in shortage?
Yes — NDC 00406888401 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).